>>> Mediobanca confirms plans to sell stakes in Telecom Italia and other compani

Mediobanca confirms plans to sell stakes in Telecom Italia and other companies

Mediobanca, the listed Italian investment bank, has confirmed plans to sell its 1.16% stake in Telecom Italia, Italian language daily Il Sole 24 Ore reported.

Mediobanca CEO Alberto Nagel said the sale of the stake in TI and a 4.1% stake in listed Italian tyre maker Pirelli is slated for 3Q15.

Nagel also said that Mediobanca would reduce its stake in listed Italian insurer Generali from 13% to 10%, most likely in 1Q16, the report added. He further noted the shares could be used to make a buy in asset management, the article added.

Nagel also confirmed that Mediobanca planned to sell its 6% stake in listed Italian media group RCS but the timing of the sale would depend on the value of RCS' shares.

The report also cited Nagel as welcoming the entry of Vivendi into TI as “great news,” as Vivendi would act as a stable shareholder.

Telecom Italia has a market cap of EUR 19.46bn.


The original article appeared in print; Page 21

Il Sole 24 Ore

(BFW) Teva CFO speaks at Oppenheimer Israel conference - Globes



http://www.globes.co.il/en/article-tevas-desheh-copaxone-has-a-long-life-ahead-of-it-1001034852
As for the proposed deal to buy Mylan, Desheh said, "Teva is a very focused company. It continually improves. We are focused on that even while we deal with the next matter (buying Mylan). Huge quantities of words have poured forth in the international and Israeli press and media. I shan't say anything new on the subject. Teva told Mylan that it was interested in buying it. It was done in a correct, orderly and respectful way, and received the response you have all seen. This response received a respectful and orderly response from us that talked about substance. We believe that the deal will create consolidation in the generics industry, that it's the right deal, for Teva, Mylan and the shareholders. It's that rare kind of deal that can generate value for the shareholders of both companies. "For anyone who doesn't remember, we work for our shareholders, and not the other way around. Creating value for the shareholders is one of the main goals. There are other goals: the workers are important, as are the customers, but the people who pay our salaries are the shareholders. Analysts who have looked and analyzed, people who cover the industry, say that this is a deal that can generate significant value, at a low level of risk."



Teva CFO Says Recent Acquisitions Can Replace Copaxone Sales
2015-05-10 08:41:18.392 GMT


By David Wainer
(Bloomberg) -- Eyal Desheh tells Tel Aviv conference co.
offering significant premium for Mylan, remains committed to
bid.
* Teva-Mylan deal “better” than Mylan-Perrigo merger: Desheh
* Deal will create “significant” value
* Teva working on raising financing
* NOTE: Teva Said to Seek $25 Billion in Financing for Mylan
Deal (2)
* NOTE: Teva Completes Acquisition of Auspex Pharmaceuticals


For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
David Wainer in Tel Aviv at +972-3-542-7110 or
dwainer3@bloomberg.net
To contact the editors responsible for this story:
Samuel Potter at +971-4-3641050 or
spotter33@bloomberg.net
Matthew Kalman, Alisa Odenheimer

(BFW) Saint-Gobain Remains Open for Talks With Sika Board, CEO Says



Saint-Gobain Remains Open for Talks With Sika Board, CEO Says
2015-05-10 12:46:34.67 GMT


By Jan-Henrik Förster
(Bloomberg) -- Saint-Gobain is still open to discuss future
governance of Sika with co.’s board, CEO Pierre-Andre de
Chalendar says in letter to Sika investors, employees and other
stakeholders.
* Says he has no doubt on legality of transaction between
Burkard family and Saint Gobain
* Says the longer it takes to realize industrial logic of
deal, the longer it takes to create value for holders
* Repeats that no restructuring is planned due to purchase
* NOTE: Sika Board Signals Open for Talks to Ease Takeover
Deadlock


For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Jan-Henrik Förster in Zurich at +41-44-224-4116 or
jforster20@bloomberg.net
To contact the editor responsible for this story:
Mariajose Vera at +49-89-244478-803 or
mvera1@bloomberg.net

(BFW) China Still Has Room for Cuts to Interest Rates, RRR: BoCom



BN 05/10 11:24 *CHINA STILL HAS ROOM FOR INTEREST RATES, RRR CUTS: BOCOM

China Still Has Room for Cuts to Interest Rates, RRR: BoCom
2015-05-10 11:49:56.190 GMT


By Bloomberg News
(Bloomberg) -- PBOC cuts interest rates mainly to reduce
financing costs, according to a BoCom research report written by
analysts led by chief economist Lian Ping.
* Banks are unlikely to raise deposit rates to the ceiling as
they haven’t done that before today’s ceiling change: report
* The change could be seen as almost a completion of interest
rate liberalization: report
* China may cut reserve requirement ratio by 0.5-1 percentage
point within this yr: report


For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact Bloomberg News staff for this story:
Penny Peng in Beijing at +86-10-6649-7719 or
ppeng18@bloomberg.net

To contact the editor responsible for this story:
Andrew Monahan at +852-2977-6483 or
amonahan@bloomberg.net

(BFW) Monte Paschi Sees Possible Merger With Cooperative Banks: Sole



Monte Paschi Sees Possible Merger With Cooperative Banks: Sole
2015-05-10 08:42:48.284 GMT


By John Follain
(Bloomberg) -- Merger “makes a lot of sense from an
industrial point of view,” Fabrizio Viola, CEO of Monte Paschi,
says in interview with newspaper Sole 24 Ore.
* Viola reiterates share sale may start end-May, timing
depends on green light from ECB
* NOTE: On Friday, Monte Paschi Swings to Quarterly Profit on
Lower Bailout Costs NSN NO1P1N6VDKHT<GO>

For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
John Follain in Rome at +39-06-4520-6329 or
jfollain2@bloomberg.net
To contact the editor responsible for this story:
Alan Crawford at +49-30-70010-6237 or
acrawford6@bloomberg.net

(BFW) China Cuts 1-Year Lending Rate by 0.25 Percentage Point



BN 05/10 09:07 China Cuts 1-Year Interest Rates by 0.25 Percentage Point
BFW 05/10 09:06 *CHINA CUTS 1-YEAR INTEREST RATES BY 0.25 PERCENTAGE POINT
BFW 05/10 09:05 *CHINA CUTS 1-YEAR LENDING RATE BY 0.25 PERCENTAGE POINT
BFW 05/10 09:05 *CHINA CUTS 1-YEAR DEPOSIT RATE BY 0.25 PERCENTAGE POINT
BN 05/10 09:04 *CHINA CUTS INTEREST RATES

China Cuts 1-Year Lending Rate by 0.25 Percentage Point
2015-05-10 09:21:47.40 GMT


By Bloomberg News
(Bloomberg) -- PBOC cuts 1-yr lending rate by 0.25
percentage point to 5.1%, according to statement on central
bank’s website.
* PBOC also cuts 1-yr deposit rate by 0.25 percentage point to
2.25%, it says
* PBOC raises deposit-rate ceiling to 150% of benchmark from
130% of benchmark: statement
* Rate cut, deposit ceiling change effective May 11: statement


Link to Company News:{PBCZ CH <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact Bloomberg News staff for this story:
Penny Peng in Beijing at +86-10-6649-7719 or
ppeng18@bloomberg.net

To contact the editor responsible for this story:
Andrew Monahan at +852-2977-6483 or
amonahan@bloomberg.net

NYT : Uber Fund-Raising Points to $50 Billion Valuation

Uber Fund-Raising Points to $50 Billion Valuation

SAN FRANCISCO — Uber is fund-raising again.

The mobile car-hailing application is in early talks to raise a new round of financing that could value the start-up at $50 billion, according to a person familiar with the discussions, who spoke anonymously because the process is confidential. Uber could raise around $1.5 billion, given the amount of interest from investors in the company, the person said.

The new capital will not be used primarily for expansion purposes, unlike Uber’s previous financing rounds. Instead, the funding is strategic, with an eye on partnerships, the person said.

Uber declined to comment. The fund-raising was first reported by The Wall Street Journal.

An engineer from the service Here drives a mapping vehicle in Britain. A consortium of automakers is seeking to buy Here, and Uber is said to be bidding.Uber Joins the Bidding for Here, Nokia’s Digital Mapping ServiceMAY 7, 2015
Uber, based in San Francisco, has raised money relentlessly in recent years at rapidly swelling valuations. So far, the company has raised more than $4 billion as it moves into new markets globally, disrupting established taxi and other transportation industries by letting people request rides through their smartphones. The company was founded in 2009 and is led by Travis Kalanick, who is chief executive.

In December, Uber closed a $1.2 billion round of financing that valued it at $40 billion. The company then moved to accommodate additional investors like Baidu, the Chinese Internet giant.

That round followed one in June, when the service said that it had raised $1.2 billion at a valuation of $17 billion.

At a $50 billion valuation, Uber would be the world’s most valuable private start-up, topping the Chinese electronics maker Xiaomi, which was last valued at $45 billion. It would also be worth more than publicly traded companies like FedEx, with a market value of $48 billion, and Nissan Motor, with a capitalization of $47 billion.

The divide between Uber and other “unicorns” — Silicon Valley’s term for billion-dollar start-ups — would also grow. Even at its current $40 billion valuation, it was nearly triple that of other elite Silicon Valley start-ups like the data analysis firm Palantir, according to the research firm CB Insights. Among Silicon Valley start-ups, only Facebook had attained a $50 billion valuation as a private company.

Uber’s new fund-raising discussions come as many Silicon Valley start-ups have been on a fund-raising tear. This week alone, the lending start-up Affirm said it has raised $275 million in debt and equity at an undisclosed valuation, while Zenefits, a software-as-a-service start-up, said it had raised $500 million at a valuation of $4 billion. The fund-raising has also taken place against a more compressed time period, with Zenefits boosting its war chest in less than a year from a previous financing round.

The action is not only taking place in the United States. This week, drone maker DJI, which is based in Shenzhen, China, said it raised $75 million from venture capital firm Accel Partners.

(Reuters) Exclusive: Mylan chairman tells investors he would consider buying Tev

Exclusive: Mylan chairman tells investors he would consider buying Teva

Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to sell itself to Israeli rival Teva Pharmaceuticals Industries Ltd (TEVA.TA), but would consider buying that company down the road, Mylan Executive Chairman Robert Coury told investors this week.

The company has been steadfast in its refusal to combine with Teva and is instead encouraging shareholders to support its own $34 billion unsolicited offer for over-the-counter drugmaker Perrigo Co Plc (PRGO.N).

Teva made an unsolicited $40 billion bid for Mylan last month, and it was rejected. Teva said on Tuesday it will move ahead with its plans to acquire Mylan if the Perrigo deal is not completed.

Mylan's Coury said in a statement in April the company has studied a possible combination with Teva for some time. Mylan concluded a deal would be "without sound industrial logic or cultural fit" and would attract antitrust scrutiny.

Mylan said in April it would not engage with Teva until the company was willing to offer more than $100 per share.

Speaking privately to investors this week, however, Coury was more willing to consider a deal with Teva after the Perrigo transaction is completed, as long as Mylan is the buyer, sources told Reuters.

Mylan Chief Executive Officer Heather Bresch explained to Reuters in an interview the logic behind Coury's comments. Mylan has a better management team and integrated global supply chain, as well as a superior track record with acquisitions. That would make it more capable than Teva to lead the potential combined company, she said.

A deal could make sense following a Mylan-Perrigo combination and more time for Teva's management to "clean up" the company.

"We were just saying in a hypothetical situation, if it ever were to happen after all these other things, the only way it could happen is with us," Bresch said. She added antitrust concerns would still exist.

The investor sources declined to be named because they are not authorized to speak with the media.

A Teva spokesman said the company remains deeply committed to a deal with Mylan and that there is strong strategic and cultural fit in combining the two companies.

Mylan management is meeting privately with top investors this week in New York and Boston to drum up support for its bid for Perrigo. Perrigo last week rejected Mylan's latest offer worth $75 and 2.3 Mylan shares per Perigo share, up from a previous $60 in cash and 2.2 shares.

Mylan, which makes the EpiPen product for severe allergies, is incorporated in the Netherlands and can take advantage of Dutch provisions that would make a hostile takeover difficult.

Pressure has been growing on Jerusalem-based Teva for new revenue sources. Its biggest selling drug, multiple sclerosis injectable treatment Copaxone, faces competition from oral treatments and cheaper generics in the coming years.

>>> PartnerRe suitor Exor has strong rationale to raise bid, bankers say - Anal

Deal Reporter

PartnerRe suitor Exor has strong rationale to raise bid, bankers say - Analysis

Exor (BIT:EXO) is seen as having a strong rationale to raise its bid for PartnerRe (NYSE:PRE) even as it remains unclear whether its previously tabled offer is superior, said industry bankers and a shareholder.

Earlier today, Reuters reported that at Exor’s board, at its meeting on Tuesday, will consider bumping its USD 6.4bn bid for PartnerRe in response to Axis Capital Holdings’ (NYSE:AXS) own sweetener. Exor interrupted Axis’ proposed nil-premium merger of equals last month, prompting Axis to add a USD 11.50-per-share dividend to its offer.

Exor’s current proposal values PartnerRe at USD 130 per share and is all-cash. Axis’ improved offer implies a valuation of USD 125 per share, and argues that synergies bridge the gap in value.

Governance groups whose recommendations are influential amongst shareholders have yet to weigh in, creating an opportunity for Exor to sway investors now with a minor bump, the first banker said.

Investors might also require a bump from Exor to be comfortable with the rival offer given PartnerRe management’s recommendation to go forward with the Axis deal, said a minor PartnerRe shareholder.

Still, the shareholder said Exor's current cash offer is already stronger than the Axis sweetener. The cash offer likely exceeds the value of future synergies between the fundamentally different entities Axis and PartnerRe, he said, and removes the risk that they might not be realized.

The Axis deal is also less certain because it carries execution risk, the shareholder said. Axis founder John Chairman warned against his former company making an overly dilutive counterbid that could harm Axis, prior to Axis’ decision to bump its offer. If his view is shared by other Axis shareholders, they could tank the proposed merger of equals at the shareholder vote required to validate the deal.

Axis and PartnerRe have yet to schedule the shareholder vote. A person briefed on the matter suggested a late June to early July timeframe.

An Axis shareholder revolt is made more likely by recent takeover rumors, the shareholder argued. A direct insurance provider capable of capturing greater synergies could step in to bid for Axis, likely at a premium to its dilutive proposed deal, he said, asking, “Then what happens to PartnerRe?”

As recently as yesterday, Exor remained confident that its bid was financially and strategically superior to Axis’ sweetened proposal, said a person briefed on the matter. Exor declined to comment when reached today.

While Exor could stay on the sidelines in the hopes that the Axis deal crumbles, two industry bankers said the company is more likely to be proactive.

Exor is unlikely to have gone public with its best and final bid as an initial gesture, the bankers said. The Agnelli family, Exor’s owner, is known for savvy deal-making and is being advised by BDT & Co., a bank with deep expertise in hostile deals, the first banker said. One of BDT’s members organized the buyout consortium from which Alleghany (NYSE:Y) emerged to buy Transatlantic Re (NYSE:TRH) in 2011, ending a five-month takeover battle among Allied World (NYSE:AWH), Berkshire Hathaway (BRK.A/B), Enstar (NASDAQ:ESGR) and Validus Holdings (NYSE:VR).

The current bid probably represents a fair value for PartnerRe, but Exor’s deep pockets would allow for a sweetener, the bankers said.

(Barron's) Cover Story : Honeywell’s Shares Are a Better Bet Than GE’s

Honeywell’s Shares Are a Better Bet Than GE’s

The industrial company has delivered the kind of results for a decade that GE is now hoping to produce.

Long-suffering General Electric shareholders had cause to cheer last month when the conglomerate announced it would shed its finance arm to focus on its core industrial business. Honeywell International investors may have even more reason to celebrate. Through the huge overhaul, GE has indicated that it can deliver 10% earnings growth annually from its industrial side in the next four years, compared with about half that in its previous form. But Honeywell, an established industrial player, remade itself more than a decade ago and has been delivering on promises of 10%-plus profit growth ever since. It expects to continue to generate that level of growth over the next five years, and, based on its record, there’s every reason to believe it.

In contrast to GE (ticker: GE), which saw its shares lose 33% of their value in the past 13 years as its strategy meandered and its massive financial operations foundered, Honeywell’s stock (HON) has risen 200%. Sales have nearly doubled to $40 billion, and its market value has mushroomed to $80 billion from $20 billion.

Honeywell CEO David Cote has made good on his promises. Photo: Gary Spector for Barron's
The Morristown, N.J.–based company has achieved this growth by successfully managing scores of products, ranging from its familiar home thermostats to sophisticated airplane-cockpit controls to security systems and turbochargers.

Having met an aggressive five-year growth plan that ended in 2014, Honeywell has greater ambitions today. “The stuff that we have coming is even more exciting than the stuff we’ve already done,” says David Cote, the outspoken chief executive responsible for revamping and reinvigorating Honeywell since coming on board in 2002. “We do a very good job of ‘seed planting,’ ” says the GE alumnus and onetime contender to succeed former CEO Jack Welch.

With most of Honeywell’s major businesses doing well, its shares, trading last week at $101.58 -- 16.6 times this year’s expected earnings -- could appreciate by about 20% in the next year and by close to 50% longer term. That’s if it continues to live up to its forecasts and to improve margins. After a recent dividend hike, the stock yields 2%. Shareholders of GE, which fetches a premium to Honeywell, face a more uncertain path.

“Whatever GE can grow at, Honeywell can grow faster and with less risk,” says Scott Lawson, portfolio manager and industrials analyst at Dallas-based Westwood Holdings Group, with $20 billion under management. He expects Honeywell to increase earnings by 12% a year in the next three years, based on management projections. “I am making the assumption Honeywell management will perform with the consistency and proficiency they’ve displayed in the past 10 years,” says Lawson.

HONEYWELL DIVIDES ITS BUSINESSES into three segments: aerospace and avionics, which are responsible for 39% of sales; automation and controls, which kicks in 36%; and performance materials, which contributes 25%.

Aerospace is benefiting from new contracts and more flight hours, while avionics has gained market share, aided by strong demand for its cockpit systems. The segment also should get a lift as U.S. defense spending stabilizes and foreign defense budgets expand.

The automation and control unit, which includes heating, cooling, lighting, and security systems for homes and businesses, is expected to grow 4% to 5% annually over the next few years. Commercial sales have been picking up, and demand for “smart” systems and energy-efficient buildings plays to Honeywell strengths.

Even the performance-materials unit, which has been affected by the ailing oil and gas industry, is expected to make a strong contribution. One big opportunity is its Solstice air-conditioning refrigerant, which stands to gain as European countries require new cars to use a low global-warming refrigerant. That should help the group generate 5% to 6% sales growth.

Honeywell is diversified across business lines and geography, with 45% of revenue coming from the U.S.; 32% from other developed countries; and 23% from developing countries, including China and India. More and more, the focus is on emerging markets, or what Cote refers to as “high-growth regions,” where sales are rising by 10% a year.

All of these businesses are tied together by the operating prowess of Cote and his disciplined management team. A process wonk, Cote is a devotee of W. Edwards Deming, an American engineer and management consultant whose theories were adopted by the Japanese following World War II. They are credited as the force behind the country’s postwar economic revival. Cote has sent managers to Toyota car plants in Kentucky to learn more about the production techniques Deming espoused.


Cote’s latest innovation is the Honeywell Operating System “Gold” program, giving more decision-making power to managers at 74 units within its aerospace, performance-materials, and automation-and-control divisions. The idea is to foster a more entrepreneurial culture that’s responsive to customers and gets product to market faster using the support and efficiencies of a large company.

The CEO is best known for his skill in identifying the best mix of high-margin businesses, boosting productivity, negotiating on prices, keeping costs low, and creating a positive, striving culture.

One indication of his management success: Honeywell has supplanted GE as the favorite hunting ground for executive-search firms looking to fill top jobs.

“We are really going to just drive the hell out of growing a lot faster than anybody else,” says Cote of his team’s objectives.

ASIDE FROM THE ABILITY to make things efficiently, Honeywell offers investors a balance sheet with $7 billion in cash, a selective appetite for acquisitions, a commitment to buy back shares under the right conditions, and a dividend that has risen 10 times since 2005. Its pension fund is practically fully funded.

So you can forgive Cote if he sounds like Rodney Dangerfield at times, complaining that his stock doesn’t get the respect Honeywell’s performance deserves.

He points to the company’s relatively strong first-quarter results in a tough environment: Earnings rose 10%, to $1.1 billion -- the high end of guidance -- while operating profit margins expanded by more than two percentage points. The company raised its earnings outlook for the year, to $6 to $6.15 a share from $5.95 to $6.15.

Although sales came in weaker than expected, they still grew 2% on an organic basis. Pinched by foreign-currency hedging and the divestiture of a business, Honeywell reduced its full-year sales revenue forecast to $39 billion to $39.6 billion from $40.5 billion to $41.1 billion. The company maintained its full-year cash-flow guidance of $4.2 billion to $4.3 billion, up from $3.9 billion a year ago. All in all, Honeywell turned in one of the top performances in the industrial group.

“I think we’re underrated based on our financial performance” is a frequent Cote lament and one he reiterated in our recent phone interview. “We have the lowest price/earnings multiple out there.”

At its recent price, Honeywell trades at 15 times 2016 earnings estimates of $6.69 a share (see table below). That’s well below the 17 times that investors assign to multi-industrial companies on average. Competitors such as GE, 3M (MMM), and Danaher (DHR) trade well above 17 times. By comparison, the Standard & Poor’s 500 is priced at 16 times forward earnings, and its earnings growth rate is a relatively paltry 5%.


Some contend Honeywell should command a premium to its peers not only because of its consistent growth but also for its high-margin software capabilities. More than half of its 22,000 engineers are software developers, and many of its advances, such as building management systems and intelligent sensors for offices and homes, are software driven. That gives it the characteristics of a technology stock, says Jon Naimon, of New York–based Light Green Advisors. It’s just a lot cheaper.

Naimon adds that software-based businesses get a high portion of recurring revenue and higher margins than other businesses. “It’s an underrated high-tech company whose software assets aren’t well recognized,” he says. The stock, Naimon says, would be more fairly valued at a multiple closer to Danaher’s, resulting in a price of about $120 a share.

ONE KNOCK AGAINST Honeywell has been that its profit margins fall short of competitors’. But the gap is closing rapidly as it controls costs more tightly and moves into more profitable businesses. Margins have expanded to 16.6% from 13% in 2009 and are expected to approach peers’ by 2018.

Some critics have also groused about the firm’s capital allocation, questioning the lack of acquisitions. In December, it agreed to buy Datamax-O’Neil, a maker of printers used in bar-code scanning, from Dover for under $200 million, but high prices have kept it from making any major purchases in the past 12 to 18 months.

“We’ve come too far in 13 years to all of a sudden lose our minds when it comes to acquisitions,” Cote notes. “I’m going to stay pretty conservative. We will continue to actively look, but we are going to be smart about it, too, because getting the right price makes a difference.”

COTE IS RIGHT about how far Honeywell has come. It was in disarray when he took the reins in 2002, after a merger with Allied-Signal in 1999 (it took the Honeywell name) and a subsequent, failed bid by GE to buy the company.

Cote was recruited from TRW by former Allied-Signal chief Lawrence Bossidy, also a GE alum. Bossidy had come out of semi-retirement to help restore order after the European Commission had scuttled the GE takeover.

Cote tightened accounting controls, brought together warring political factions, and cut costs. Most importantly, he re-established the company’s credibility, most recently by meeting its five-year plan through 2014. Now, Cote and his team are focused on their new plan, which extends to 2018.

At Honeywell’s March investor conference, Cote ticked off a number of goals. He expects 4% to 6% average annual-sales growth from existing businesses, bringing total revenue to $46 billion to $51 billion; an additional $5 billion to $8 billion in revenue could come from strategic mergers and acquisitions. That would result in an extra $1 a share in earnings that could exceed $9 a share by 2018.

If M&A falls short and net cash exceeds $1 billion to $2 billion, Cote is committed to buying back shares to get the extra bang in earnings per share.

Continued operational improvements and cost containment will lift margins by another two percentage points, to 18.5% or more from the 16.6% in 2014. Cote expects Honeywell to generate $30 billion to $33 billion in cash -- $10 billion of that to be paid out in dividends. He’s also targeting a dividend payout ratio of 40%, up from the current 34%.

“The outperformance is going to continue,” Cote vows. Taking him at his word has usually proved profitable to Honeywell shareholders. GE investors can only wait and hope things work out.